Mast cells are an important cellular source of tumour necrosis factor in human intestinal tissue

Gut

Volumn 44, Issue 5, 1999, Pages 643-652

  Bischoff, S C ^a   Lorentz, A ^a   Schwengberg, S ^a   Weier, G ^a   Raab, R ^a   Manns, M P ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Bacteria; Inflammatory bowel disease; Mast cells; Tumour necrosis factor

Indexed keywords

IMMUNOGLOBULIN E RECEPTOR; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL ISOLATION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; ENTERITIS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREGULATION; INTESTINE EPITHELIUM; MAST CELL; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN EXPRESSION;

EID: 0032966506     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.44.5.643     Document Type: Article

References (47)

1. 1 Bazzoni F, Beutler B. The tumor necrosis factor ligand and receptor families. N Engl J Med 1996;334:1717-25.
2. 2 Van Deventer SJH. Tumor necrosis factor and Crohn's disease. Gut 1997;40:443-8.
3. 3 Van Overfeld FJ, Jorens PG, Rampart M, et al. Tumor necrosis factor stimulates human skin mast cells to release histaminc and tryptase. Clin Exp Allergy 1991;21:711-14.
4. 4 Paleolog EM, Delasalle SA, Buurman WA, et al. Functional activities of tumor necrosis factor alpha on human vascular endothelial cells. Blood 1994;84:2578-90.
5. 5 Costa JJ, Matossian K, Resnick MB, et al. Human eosinophils can express the cytokines tumor necrosis factor-α and macrophage inflammatory protein-1α. J Clin Invest 1903;91:2673-84.
6. εRI. A mechanism for the sustained action of mast cell-derived TNFα during IgE-dependent biological responses. J Exp Med 1991;174: 103-7.
7. 7 Echternacher B, Mannel DN, Hultner L. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 1996;381:75-7.
8. 8 Malaviya R, Ikeda T, Ross E, Abraham SN. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha. Nature 1996;381:77-80.
9. 9 Targan SR, Hannauer SB, van Deventer SJH, et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor α for Crohn's disease. N Engl J Med 1997;337:1029-35.
10. 10 Moreland LW, Baumgartner SW, Schiff MH, et al. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N Engl J Med 1997;337:141-7.
11. 11 Galli SJ. New concepts about the mast cell. N Engl J Med 1993;328:257-65.
12. 12 Bischoff SC. Mucosal allergy: role of mast cells and eosinophil granulocytes in the gut. Ballieres Clin Gastroenterol 1996;10:443-59.
13. 13 Furuta GT, Schmidt-Choudhury A, Wang MY, et al. Mast cell-dependent tumor necrosis factor a production participates in allergic gastric inflammation in mice. Gastroenterology 1997;113:1560-9.
14. 14 Zhang Y, Ramos B, Jakschik BA. Neutrophil recruitment by tumor necrosis factor from mast cells in immune complex peritonitis. Science 1992;258:1957-9.
15. 15 Wershil BK, Wang ZS, Gordon JR, et al. Recruitment of neutrophils during IgF-dependent cutaneous late phase reactions in the mouse is mast cell-dependent. J Clin Invest 1991;87:446-53.
16. 16 Bradding P, Mediwake R, Feather ICH, et al. TNF alpha is localized to nasal mucosal mast cells and is released in acute allergic rhinitis. Clin Exp Allergy 1995;25:406-15.
17. 17 Walsh LJ, Trinchieri G, Waldorf HA, et al. Human dermal mast cells contain and release tumor necrosis factor alpha, which induces endothelial leukocyte adhesion molecule 1. Proc Natl Acad Sci USA 1991;88:4220-4.
18. 18 Bradding P, Roberts JA, Britten KM, et al. Interleukins (IL)-4, -5, -6, and TNF-α in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol 1994;10:471-80.
19. 19 Bischoff SC, Schwengberg S, Wordelmann K, et al. Effect of c-kit ligand, stem cell factor, on mediator release by human intestinal mast cells isolated from patients with inflammatory bowel disease and controls. Gut 1996;28:104-14.
20. 20 Bischoff SC, Schwengberg S, Raab R, et al. Functional properties of human intestinal mast cells cultured in a new culture system: enhancement of IgE receptor-dependent mediator release and response to stem cell factor. J Immunnol 1997;159:5560-7.
21. 21 Riske F, Hakimi J, Mallamaci M, et al. High affinity human IgE receptor (FcεRI). Analysis of functional domains of the a subunit with monoclonal antibodies. J Biol Chem 1991;266:11245-51.
22. 22 Okayama Y, Hunt TC, Kassel O, et al. Assessment of the anti-c-kit monoclonal antibody YB5.B8 in affinity magnetic enrichment of human lung mast cells. J Immunol Methods 1994;169:153-61.
23. 23 Lerner KB, Nocka KH, Cole SR, et al. Monoclonal antibody YB5.B8 identifies the human c-kit protein product. Blood 1991;77:1876-83.
24. 24 Bischoff SC, Dahinden CA. Effect of nerve growth factor on the release of inflammatory mediators by mature human basophils. Blood 1992;79:2662-9.
25. 25 Laemmli UK. Cleavage of structural proteins during the assembly of the head of bactriophage T4. Nature 1970;227: 680-5.
26. 26 Wong H, Anderson WD, Cheng T, et al. Monitoring mRNA expression by polymerase chain reaction: the "primer dropping method". Anal Biochem 1994;223:251-8.
27. 27 Kremlev SG, Umstead TM, Phelps DS. Surfactant protein A regulates cytokine production in the monocytic cell line THP-1. Am J Physiol 1997;227:L996-L1004.
28. 28 Bischoff SC, Wedemeyer J, Herrmann A, et al. Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel disease. Histopathology 1996;28:1-13.
29. 29 Stalder AK, Campbell IL. Simultaneous analysis of multiple cytokine receptor mRNAs by RNAse protection assay in LPS-induced endotoxemia. Lymphokine Cytokine Res 1994; 13:107-12.
30. 30 Valent P, Besemer J, Sillaber C, et al. Failure to detect IL-3-binding sites on human mast cells. J Immunol 1990;145: 3432-7.
31. 31 Weidner X, Austen KF. Heterogeneity of mast cells at multiple body sites. Path Res Pract 1993;189:156-62.
32. 32 Bradding P, Okayama Y, Howarth PH, et al. Heterogeneity of human mast cells based on cytokine content. J Immunol 1995;155:297-307.
33. 33 Beil WJ, Weller PF, Peppercorn MA, et al. Ultrastructural immunogold localization of subcellular sites of TNF-alpha in colonie Crohn's disease. J Leukoc Biol 1995;58:284-98.
34. 34 Murch SH, Braegger CPS Walker-Smith JA, et al. Location of tumour necrosis factor a by immunohistochemisiry in chronic inflammatory bowel disease. Gut 1993;34:1705-9.
35. 35 Reinecker HC, Steffen M, Witthoeft T, et al. Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1β by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol 1993;94:174-81.
36. 36 Tashiro M, Kawakami Y, Abe R, et al. Increased secretion of TNF-α by costimulation of mast cells via CD28 and FceRI. J Immunol 1997;158:2382-9.
37. 37 Benyon RC, Bissonnette EY, Befus AD. Tumor necrosis factor-α dependent cytotoxicity of human skin mast cells is enhanced by anti-IgE antibodies. J Immunol 1991;147: 2253-8.
38. 38 Mattson E, Van Dijk H, Van Kessel K, et al. Intracellular pathways involved in tumor necrosis factor-α release by human monocytes on stimulation with lipopolysaccharide or staphylococcal peptidoglycan are partly similar. J Infect Dis 1996;173:212-18.
39. 39 Bischoff SC, Dahinden CA. C-kit ligand: a unique potentiator of mediator release by human lung mast cells. J Exp Med 1992;175:237-44.
40. 40 Leal-Berumen I, Conlon P, Marshall JS. IL-6 production by rat peritoneal mast cells is not necessarily preceded by histamine release and can be induced by bacterial lipopolysaccharide. J Immunol 1994;152:5468-76.
41. 41 Lin TJ, Bissonnette EY, Hirsh A, et al. Stem cell factor potentiates histamine secretion by multiple mechanisms, but does not affect tumour necrosis factor-α release from rat mast cells. Immunology 1996;89:301-7.
42. 42 Marshall JS, Leal Berumen I, Nielsen L, et al. Interleukin (IL)-10 inhibits long-term IL-6 production but not preformed mediator release from rat peritoneal mast cells. J Clin Invest 1996;97:1122-8.
43. 43 Arock M, Zuany-Amorim C, Singer M, et al. Interleukin-10 inhibits cytokine generation from mast cells. Eur J Immunol 1996;26:166-70.
44. 44 Van Deventer SJH, Elson CO, Fedorak RN. Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease. Gastroenterology 1997;113:383-9.
45. 45 Eklund KK, Humphries DE, Xia Z, et al. Glucocorticoids inhibit the cytokine-induced proliferation of mast cells, the high-affinity IgE receptor-mediated expression of TNF-α, and the IL-10-induced expression of chymases. J Immunol 1997;158:4373-80.
46. 46 Bissonnette EY, Enciso JA, Befus AD. Inhibitory effects of sulfasalazine and its metabolites on histamine release and TNE-α production by mast cells. J Immunol 1996;156:218-23.
47. 47 Bissonnette EY, Chin B, Befus AD. Interferons differentially regulate histamine and TNF-a in rat intestinal mucosal mast cells. Immunology 1995;86:12-17.